Taiwan · Delayed Price · Currency is TWD AnnJi Pharmaceutical Statistics
Total Valuation
TPEX:7754 has a market cap or net worth of TWD 5.75 billion. The enterprise value is 5.45 billion.
| Market Cap | 5.75B |
| Enterprise Value | 5.45B |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:7754 has 94.06 million shares outstanding. The number of shares has increased by 1.10% in one year.
| Current Share Class | 94.06M |
| Shares Outstanding | 94.06M |
| Shares Change (YoY) | +1.10% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 1.83% |
| Owned by Institutions (%) | 12.45% |
| Float | 54.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 761.03 |
| PB Ratio | 17.97 |
| P/TBV Ratio | 22.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.22 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.43 |
Financial Position
The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.60 |
| Quick Ratio | 3.40 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -230.71 |
Financial Efficiency
Return on equity (ROE) is -72.89% and return on invested capital (ROIC) is -42.49%.
| Return on Equity (ROE) | -72.89% |
| Return on Assets (ROA) | -29.00% |
| Return on Invested Capital (ROIC) | -42.49% |
| Return on Capital Employed (ROCE) | -75.79% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.28 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +250.29% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +250.29% |
| 50-Day Moving Average | 58.54 |
| 200-Day Moving Average | 46.50 |
| Relative Strength Index (RSI) | 46.34 |
| Average Volume (20 Days) | 313,215 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:7754 had revenue of TWD 7.55 million and -357.87 million in losses. Loss per share was -3.81.
| Revenue | 7.55M |
| Gross Profit | 1.26M |
| Operating Income | -369.37M |
| Pretax Income | -357.87M |
| Net Income | -357.87M |
| EBITDA | -331.86M |
| EBIT | -369.37M |
| Loss Per Share | -3.81 |
Balance Sheet
The company has 348.47 million in cash and 49.36 million in debt, with a net cash position of 299.11 million or 3.18 per share.
| Cash & Cash Equivalents | 348.47M |
| Total Debt | 49.36M |
| Net Cash | 299.11M |
| Net Cash Per Share | 3.18 |
| Equity (Book Value) | 319.82M |
| Book Value Per Share | 3.40 |
| Working Capital | 267.00M |
Cash Flow
In the last 12 months, operating cash flow was -350.29 million and capital expenditures -2.91 million, giving a free cash flow of -353.20 million.
| Operating Cash Flow | -350.29M |
| Capital Expenditures | -2.91M |
| Depreciation & Amortization | 45.16M |
| Net Borrowing | -5.98M |
| Free Cash Flow | -353.20M |
| FCF Per Share | -3.75 |
Margins
| Gross Margin | 16.64% |
| Operating Margin | -4,891.01% |
| Pretax Margin | -4,738.73% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:7754 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.10% |
| Shareholder Yield | -1.10% |
| Earnings Yield | -6.23% |
| FCF Yield | -6.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:7754 has an Altman Z-Score of 1.75 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.75 |
| Piotroski F-Score | 2 |